Contact this trialFirst, we need to learn more about you.
Androgen Deprivation Therapy
Talazoparib + ADT + Abiraterone for Prostate Cancer
Recruiting2 awardsPhase 2
Duarte, California
This trial is studying the effect of talazoparib with androgen deprivation therapy and abiraterone in treating patients with castration sensitive prostate cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service